Form D — Pacific Diabetes Technologies, Inc.
0001835476-25-000001 · filed Mar 14, 2025
Figures are issuer-reported and describe stored filings. Data coverage and methodology.
Check this disclosure on SEC EDGAR · More Biotechnology filings
Offering
- Industry
- Biotechnology
- Exemptions
- Rule 506(b)
- Reported offering amount
- $5,000,000
- Reported amount sold
- $2,057,533
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Pacific Diabetes Technologies, Inc.
- CIK
- 1835476
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2021
- Address
- 12172 SW GARDEN PL
PORTLAND, Oregon 97223 - Phone
- 503-847-9170
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Thomas Seidl · Executive OfficerPortland, Oregon Find on LinkedIn ↗
-
Peter Eckenberg · DirectorPortland, Oregon Find on LinkedIn ↗
-
Ed La Cava · DirectorPortland, Oregon Find on LinkedIn ↗
-
Kenneth Ward · DirectorPortland, Oregon Find on LinkedIn ↗
-
Christopher Marsh · DirectorPortland, Oregon Find on LinkedIn ↗
-
Hank Wuh · DirectorPortland, Oregon Find on LinkedIn ↗
-
Mark Huber · DirectorPortland, Oregon Find on LinkedIn ↗
Other filings from this issuer
View the original filing on SEC EDGAR ↗